4 results  1 of 1 

1 Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
Alessandro Cavaliere, Valeria Merz, Simona Casalino, Camilla Zecchetto, Francesca Simionato, Hayley Louise Salt, Serena Contarelli, Raffaela Santoro, Davide Melisi
J Gastric Cancer.2019;19(4):375-392.   Published online 2019 November 13     DOI: http://dx.doi.org/10.5230/jgc.2019.19.e39
      
2 Expression of c-IAP1, c-IAP2 as of Inhibitor of Apoptosis Proteins in Cervical and Ovarian Cancers
Jun Hyung Cho, Chi Heum Cho, Sang Hoon Kwon, Won Ki Baek, Kun Young Kwon, Jun Cheol Park, Jung Ho Rhee, Jong In Kim, Sung Do Yoon, Soon Do Cha
Korean J Gynecol Oncol Colposc.2003;14(1):21-29.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgoc.2003.14.1.21
      
3 The Immunohistochemical analysis for the expression of survivin, an inhibitor of apoptosis protein, in non-small cell lung cancer
Mi Hye Ko, Na Hye Myoung, Jae Whan Lee, Eun Mi Cho, Jae Seuk Park, Keun Youl Kim, Kye Young Lee
Tuberc Respir Dis.2000;48(6):909-921.   Published online 2016 March 11     DOI: http://dx.doi.org/10.4046/trd.2000.48.6.909
      
4 Identification of a Variant Form of Cellular Inhibitor of Apoptosis Protein (c-IAP2) That Contains a Disrupted Ring Domain
Sun-Mi Park, Ji-Su Kim, Ji-Hyun Park, Seung-Goo Kang, Tae Ho Lee
Immune Netw.2002;2(3):137-141.   Published online 2002 September 30     DOI: http://dx.doi.org/10.4110/in.2002.2.3.137
      

 1 of 1